CANCER TREATMENT WITH ROR1 ANTIBODIES IMMUNOCONJUGATES Russian patent published in 2023 - IPC A61K47/68 A61P35/00 C07K16/28 

Abstract RU 2795560 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a method for treating a subject suffering from cancer using an immunoconjugate comprising an antibody conjugated to a medicinal product component, where the medicinal product component has the structure shown in Formula (I) below:

(I), where Ab in Formula (I) is an antibody and where the heavy chain and light chain of the antibody comprise the amino acid sequences of SEQ ID NO: 1 and 2, respectively ; and wherein the immunoconjugate is administered to a subject at a dose of 0.25 to 4.00 mg/kg, also refers to an immunoconjugate for use in the treatment of cancer in a subject in a method for treating a subject with cancer, and to the use of an immunoconjugate for the preparation of a medicament for the treatment of cancer in a subject in a method of treating a subject suffering from cancer.

EFFECT: group of inventions provides for the development of a new therapy for patients with hematological malignancies and other malignant diseases which improves outcomes for patients, including patients who do not respond to existing therapies, by targeting ROR1.

19 cl, 5 dwg, 8 tbl

Similar patents RU2795560C2

Title Year Author Number
METHODS OF TREATING USING ANTI-CD123 IMMUNOCONJUGATES 2019
  • Tsvajdler-Makkej, Patrik
  • Kalm-Merdek, Kerri
  • Sloss, Kallum
  • Romanelli, Enzhela
RU2816847C2
COMPOSITIONS OF ANTIBODIES AGAINST ROR1 AND CORRESPONDING METHODS 2017
  • Rader, Christoph
  • Peng, Haiyong
  • Beerli, Roger
  • Waldmeier, Lorenz
  • Grawunder, Ulf
RU2766190C2
METHODS AND COMPOSITIONS FOR ADMINISTRATION OF DOSES OF ALLOGENEIC T-CELLS WITH CHIMERIC ANTIGEN RECEPTOR 2018
  • Konto, Cyril Alkis
  • Zinai, Amina
RU2776322C2
CONJUGATES OF CMET ANTIBODY AND DRUG AND METHODS OF USING 2017
  • Reilly, Edward B.
  • Naumovski, Louie
  • Allan, Christian B.
  • Wang, Jieyi
  • Anderson, Mark G.
  • Afar, Daniel E.
RU2740996C2
ANTI-FOLR1 IMMUNOCONJUGATE APPLICATION SCHEMES 2014
  • Latz, Robert Dzh.
  • Ponte, Khose
RU2801307C1
NK INVOLVING MOLECULES AND METHODS OF THEIR USE 2019
  • Miller, Jeffrey, S.
  • Felices, Martin
  • Vallera, Daniel Attilio
  • Lenvik, Todd, R.
RU2812481C2
MULTI-SPECIFIC ANTIBODIES AND METHODS OF THEIR PRODUCTION AND USE 2018
  • Zhu, Yi
  • Olsen, Ole
  • Xia, Dong
  • Jellyman, David
  • Bykova, Katrina
  • Rousseau, Anne-Marie
  • Brady, Bill
  • Renshaw, Blair
  • Kovacevich, Brian
  • Liang, Yu
  • Gao, Zeren
RU2811477C2
ANTIBODY-DRUG CONJUGATES CONTAINING HERBOXYDIENE-BASED SPLICING MODULATOR, AND METHODS OF USE THEREOF 2019
  • Fishkin, Nathan
  • Samarakoon, Thiwanka
  • Palacino, James
  • Arai, Kenzo
  • Kotake, Yoshihiko
  • Okubo, Shinya
  • Murai, Norio
  • Miyano, Masayuki
RU2820607C2
ANTIBODIES AGAINST CD79b, DRUG CONJUGATES AND THEIR USE 2019
  • Han Nianhe
  • Song Liwei
  • An Deqiang
  • Zeng Di
  • Li Huali
  • Yang Chun
RU2805251C2
METHODS FOR MODULATING CART-CELLS 2017
  • Albertson, Tina
RU2774232C2

RU 2 795 560 C2

Authors

Miller, Langdon

Lannutti, Brian

Jessen, Katti

Dates

2023-05-05Published

2020-02-01Filed